Diagnostic technique reveals biomarker differentiating bladder cancer from inflammation

| February 12, 2019

article image
Label-free digital pathology using infrared (IR) imaging with subsequent proteomic analysis for bladder cancer (BC) has revealed the first protein biomarker (AHNAK2) for BC. AHNAK2 differentiates between chronic cystitis (inflammation of the bladder) and a non-muscle invasive-type BC (carcinoma in situ) which is challenging to diagnose. The report describes this new diagnostic procedure, which is label-free, automated, observer-independent, and as sensitive and specific as established histopathological methods.

Spotlight

Cascadia Behavioral Healthcare

The mission of Cascadia Behavioral Healthcare is to create hope and opportunity for low income people with mental illnesses and addictions, blending innovation and determination with competence, inclusion and compassion. The heart of Cascadia is our people those we serve, our co-workers, and our community partners. Together we are focused on efficiency, committed to diversity and grounded in compassion.We are consumers, counselors, accountants, case managers, nurses, administrative support workers, doctors, and the full complement of all the people needed to bring results. For many of us this is not just a job, it’s a calling.

OTHER ARTICLES

Advance Your Pharma Supply Chain Planning during a Pandemic

Article | March 20, 2020

One predominant and common element within our pharmaceutical industry, is our devotions to patients. Within supply chain there is always a focus on ensuring the right product is delivered to the right place at the right time in order to ensure patient safety and the continuity of medicinal supplies. With the spread of COVID-19 across 117 countries and counting, every supply chain needs to evaluate their global footprint and develop contingency plans within their end to end operations.

Read More

Decentralized Clinical Trials: Imperative for Pharma Sector to fight COVID19

Article | March 20, 2020

These are unprecedented times. The world is mobbed by a contagion virus, putting people’s health at risk, threatening to destabilize economies. It has already put global healthcare systems under tremendous pressures, and managed to resist efforts to contain it. Even though coronaviruses are not new, this COVID-19 strain has created panic and forced us to be locked down in our homes sans any movement for weeks, if not months. Organizations are fighting an intense battle to keep their workforce safe, minimize risk, and ensure business continuity. For the Life Sciences industry, however, the challenge is even more significant. The whole world is looking at them to come up with a vaccine and a cure. But that is easier said than done. Bringing a new drug to market is an uphill battle and requires rigorous clinical trials. This process already has regulatory challenges. With the current lockdown situation, the Pharma community is grappled with the challenge of continuing some of the critical and time-sensitive in-flight trials so that their regulatory submission, registration, and market entry are not impacted. But all may not be lost. With the right technology solution, it is possible to turn the situation around rapidly.

Read More

Artificial intelligence in pharma: utilising a valuable resource

Article | March 20, 2020

The pharmaceutical industry is set to greatly benefit from the use of artificial intelligence (AI), due to its wide range of applications. Sydney Tierney discusses how machine learning can enhance marketing, manufacturing and drug trials. Artificial intelligence (AI) can be applied to nearly every aspect of the pharmaceutical and healthcare industry, to enhance data processing. Adopting the technology will reveal the astonishing potential of the healthcare sector, with success rates flying higher than ever before – especially in the research and development of crucial, life-changing drugs.

Read More

What are the advantages of PCD Pharma Company?

Article | March 20, 2020

PCD Pharma stands for propaganda distribution. A PCD company gives brand name and support to its franchises. They also provide distribution rights and monopoly rights within a particular region. If a person wants to establish their business, it is a must for them to know the pros and cons of the business to make a sound decision. Needless to mention that PCD company has a lot to contribute in the medical filed. Worldwide in a medical field, A PCD Pharma Company is playing an essential and crucial role in the rapid growth. The pharma industry is progressing t a fast pace. The company uses the latest technologies for each brand which ensures the safety of products and accepts the responsibility of human health & life by providing better outcomes. To have a drug license number and company registration, the cost to establish the company is quite cost-effective that is15000-20000rs. So this gives people a brilliant opportunity to have their unit without digging a big hole in their bank balance. Indian produces exquisite quality products, which make pharma companies a considerable success.

Read More

Spotlight

Cascadia Behavioral Healthcare

The mission of Cascadia Behavioral Healthcare is to create hope and opportunity for low income people with mental illnesses and addictions, blending innovation and determination with competence, inclusion and compassion. The heart of Cascadia is our people those we serve, our co-workers, and our community partners. Together we are focused on efficiency, committed to diversity and grounded in compassion.We are consumers, counselors, accountants, case managers, nurses, administrative support workers, doctors, and the full complement of all the people needed to bring results. For many of us this is not just a job, it’s a calling.

Events